TipRanks
Thermo Fisher (TMO)
NYSE:TMO
US Market
TMO
Thermo Fisher
RESEARCH TOOLSreports
Want to see TMO full AI Analyst Report?

Thermo Fisher (TMO) Stock Forecast & Price Target

5,285 Followers
See the Price Targets and Ratings of:

TMO Analyst Ratings

Strong Buy
19Ratings
Strong Buy
16 Buy
3 Hold
0 Sell
Based on 19 analysts giving stock ratings to
Thermo
Fisher
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TMO Stock 12 Month Forecast

Average Price Target

$718.83
▲(14.44% Upside)
Based on 19 Wall Street analysts offering 12 month price targets for Thermo Fisher in the last 3 months. The average price target is $718.83 with a high forecast of $830.00 and a low forecast of $575.00. The average price target represents a 14.44% change from the last price of $628.15.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"467":"$467","558":"$558","649":"$649","740":"$740","831":"$831"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":830,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$830.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":718.8333333333333,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$718.83</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":575,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$575.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[467,558,649,740,831],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,652.51,666.1630769230769,679.8161538461538,693.4692307692308,707.1223076923077,720.7753846153846,734.4284615384615,748.0815384615385,761.7346153846154,775.3876923076923,789.0407692307692,802.6938461538462,816.3469230769231,{"y":830,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,652.51,657.6117948717948,662.7135897435898,667.8153846153846,672.9171794871795,678.0189743589743,683.1207692307692,688.2225641025641,693.3243589743589,698.4261538461537,703.5279487179487,708.6297435897435,713.7315384615384,{"y":718.8333333333333,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,652.51,646.5476923076923,640.5853846153846,634.623076923077,628.6607692307692,622.6984615384615,616.7361538461538,610.7738461538462,604.8115384615385,598.8492307692308,592.886923076923,586.9246153846154,580.9623076923077,{"y":575,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":528.871,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":565.403,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":583.1,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":577.855,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":580.168,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":507.18,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":493.666,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":468.381,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":493.167,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":512.936,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":573.86,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":600.04,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":652.51,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$830.00Average Price Target$718.83Lowest Price Target$575.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on TMO
Daniel Brennan
TD Cowen
TD Cowen
$760→$810
Buy
28.95%
Upside
Assigned
10/22/26
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (NYSE: TMO) and Telix Pharmaceuticals (Other OTC: TLPPF)
UBS Analyst forecast on TMO
Doug Schenkel
UBS
UBS
$800
Buy
27.36%
Upside
Reiterated
10/22/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Perrigo Company (NYSE: PRGO), Thermo Fisher (NYSE: TMO) and Medpace Holdings (NASDAQ: MEDP)
RBC Capital Analyst forecast on TMO
Dan Leonard
RBC Capital
RBC Capital
$580→$730
Hold
16.21%
Upside
Assigned
10/22/26
RBC Capital Reaffirms Their Hold Rating on Thermo Fisher (TMO)
Robert W. Baird Analyst forecast on TMO
Catherine Ramsey Schulte
Robert W. Baird
Robert W. Baird
$723→$756
Buy
20.35%
Upside
Reiterated
10/22/26
Thermo Fisher price target raised to $756 from $723 at BairdThermo Fisher price target raised to $756 from $723 at Baird
Barclays Analyst forecast on TMO
Luke Sergott
Barclays
Barclays
$750→$775
Buy
23.38%
Upside
Reiterated
10/22/26
Barclays Sticks to Its Buy Rating for Thermo Fisher (TMO)
Stifel Nicolaus Analyst forecast on TMO
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$650→$775
Buy
23.38%
Upside
Reiterated
10/22/26
Thermo Fisher price target raised to $775 from $650 at StifelThermo Fisher price target raised to $775 from $650 at Stifel
Bank of America Securities Analyst forecast on TMO
Michael Ryskin
Bank of America Securities
Bank of America Securities
$650→$795
Buy
26.56%
Upside
Reiterated
10/22/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Thermo Fisher (NYSE: TMO) and Molina Healthcare (NYSE: MOH)
Goldman Sachs Analyst forecast on TMO
Evie Koslosky
Goldman Sachs
Goldman Sachs
$780→$830
Buy
32.13%
Upside
Reiterated
10/21/26
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (NYSE: TMO) and Zimmer Biomet Holdings (NYSE: ZBH)
Bernstein Analyst forecast on TMO
Eve Burstein
Bernstein
Bernstein
$575
Hold
-8.46%
Downside
Assigned
10/19/26
Analysts Offer Insights on Healthcare Companies: PTC Therapeutics (NASDAQ: PTCT), Immunovant (NASDAQ: IMVT) and Thermo Fisher (NYSE: TMO)
J.P. Morgan Analyst forecast on TMO
Casey Woodring
J.P. Morgan
J.P. Morgan
$690→$760
Buy
20.99%
Upside
Reiterated
10/16/26
Thermo Fisher (TMO) Gets a Buy from J.P. Morgan
Morgan Stanley Analyst forecast on TMO
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
$650→$730
Buy
16.21%
Upside
Assigned
10/13/26
Thermo Fisher price target raised to $730 from $650 at Morgan StanleyThermo Fisher price target raised to $730 from $650 at Morgan Stanley
Deutsche Bank Analyst forecast on TMO
Justin Bowers
Deutsche Bank
Deutsche Bank
$635→$720
Buy
14.62%
Upside
Reiterated
09/25/26
Thermo Fisher price target raised to $720 from $635 at Deutsche BankThermo Fisher price target raised to $720 from $635 at Deutsche Bank
CLSA Analyst forecast on TMO
Michael Luo CFA
CLSA
CLSA
$748
Buy
19.08%
Upside
Initiated
09/03/26
Thermo Fisher initiated with an Outperform at CLSAThermo Fisher initiated with an Outperform at CLSA
Piper Sandler Analyst forecast on TMO
David Westenberg
Piper Sandler
Piper Sandler
$510→$600
Hold
-4.48%
Downside
Reiterated
07/27/26
Thermo Fisher price target raised to $600 from $510 at Piper SandlerThermo Fisher price target raised to $600 from $510 at Piper Sandler
CMB International Securities Analyst forecast on TMO
Jill Wu
CMB International Securities
CMB International Securities
$620→$660
Buy
5.07%
Upside
Reiterated
07/27/26
Analysts Offer Insights on Healthcare Companies: Capricor Therapeutics (NASDAQ: CAPR) and Thermo Fisher (NYSE: TMO)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on TMO
Daniel Brennan
TD Cowen
TD Cowen
$760→$810
Buy
28.95%
Upside
Assigned
10/22/26
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (NYSE: TMO) and Telix Pharmaceuticals (Other OTC: TLPPF)
UBS Analyst forecast on TMO
Doug Schenkel
UBS
UBS
$800
Buy
27.36%
Upside
Reiterated
10/22/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Perrigo Company (NYSE: PRGO), Thermo Fisher (NYSE: TMO) and Medpace Holdings (NASDAQ: MEDP)
RBC Capital Analyst forecast on TMO
Dan Leonard
RBC Capital
RBC Capital
$580→$730
Hold
16.21%
Upside
Assigned
10/22/26
RBC Capital Reaffirms Their Hold Rating on Thermo Fisher (TMO)
Robert W. Baird Analyst forecast on TMO
Catherine Ramsey Schulte
Robert W. Baird
Robert W. Baird
$723→$756
Buy
20.35%
Upside
Reiterated
10/22/26
Thermo Fisher price target raised to $756 from $723 at BairdThermo Fisher price target raised to $756 from $723 at Baird
Barclays Analyst forecast on TMO
Luke Sergott
Barclays
Barclays
$750→$775
Buy
23.38%
Upside
Reiterated
10/22/26
Barclays Sticks to Its Buy Rating for Thermo Fisher (TMO)
Stifel Nicolaus Analyst forecast on TMO
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$650→$775
Buy
23.38%
Upside
Reiterated
10/22/26
Thermo Fisher price target raised to $775 from $650 at StifelThermo Fisher price target raised to $775 from $650 at Stifel
Bank of America Securities Analyst forecast on TMO
Michael Ryskin
Bank of America Securities
Bank of America Securities
$650→$795
Buy
26.56%
Upside
Reiterated
10/22/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Thermo Fisher (NYSE: TMO) and Molina Healthcare (NYSE: MOH)
Goldman Sachs Analyst forecast on TMO
Evie Koslosky
Goldman Sachs
Goldman Sachs
$780→$830
Buy
32.13%
Upside
Reiterated
10/21/26
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (NYSE: TMO) and Zimmer Biomet Holdings (NYSE: ZBH)
Bernstein Analyst forecast on TMO
Eve Burstein
Bernstein
Bernstein
$575
Hold
-8.46%
Downside
Assigned
10/19/26
Analysts Offer Insights on Healthcare Companies: PTC Therapeutics (NASDAQ: PTCT), Immunovant (NASDAQ: IMVT) and Thermo Fisher (NYSE: TMO)
J.P. Morgan Analyst forecast on TMO
Casey Woodring
J.P. Morgan
J.P. Morgan
$690→$760
Buy
20.99%
Upside
Reiterated
10/16/26
Thermo Fisher (TMO) Gets a Buy from J.P. Morgan
Morgan Stanley Analyst forecast on TMO
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
$650→$730
Buy
16.21%
Upside
Assigned
10/13/26
Thermo Fisher price target raised to $730 from $650 at Morgan StanleyThermo Fisher price target raised to $730 from $650 at Morgan Stanley
Deutsche Bank Analyst forecast on TMO
Justin Bowers
Deutsche Bank
Deutsche Bank
$635→$720
Buy
14.62%
Upside
Reiterated
09/25/26
Thermo Fisher price target raised to $720 from $635 at Deutsche BankThermo Fisher price target raised to $720 from $635 at Deutsche Bank
CLSA Analyst forecast on TMO
Michael Luo CFA
CLSA
CLSA
$748
Buy
19.08%
Upside
Initiated
09/03/26
Thermo Fisher initiated with an Outperform at CLSAThermo Fisher initiated with an Outperform at CLSA
Piper Sandler Analyst forecast on TMO
David Westenberg
Piper Sandler
Piper Sandler
$510→$600
Hold
-4.48%
Downside
Reiterated
07/27/26
Thermo Fisher price target raised to $600 from $510 at Piper SandlerThermo Fisher price target raised to $600 from $510 at Piper Sandler
CMB International Securities Analyst forecast on TMO
Jill Wu
CMB International Securities
CMB International Securities
$620→$660
Buy
5.07%
Upside
Reiterated
07/27/26
Analysts Offer Insights on Healthcare Companies: Capricor Therapeutics (NASDAQ: CAPR) and Thermo Fisher (NYSE: TMO)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AMRXAmneal Pharmaceuticals
DNTHDianthus Therapeutics
ONCBeOne Medicines
IRLAIRulya Therapeutics
IDYAIDEAYA Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Thermo Fisher

3 Months
Daniel AriasStifel Nicolaus
Success Rate
21/29 ratings generated profit
72%
Average Return
+5.16%
Copying Daniel Arias's trades and holding each position for 3 Months would result in 72.41% of your transactions generating a profit, with an average return of +5.16% per trade.
1 Year
Doug SchenkelUBS
Success Rate
17/18 ratings generated profit
94%
Average Return
+22.77%
Copying Doug Schenkel's trades and holding each position for 1 Year would result in 94.44% of your transactions generating a profit, with an average return of +22.77% per trade.
2 Years
Doug SchenkelUBS
Success Rate
17/18 ratings generated profit
94%
Average Return
+45.93%
Copying Doug Schenkel's trades and holding each position for 2 Years would result in 94.44% of your transactions generating a profit, with an average return of +45.93% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TMO Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
30
30
22
23
19
Hold
6
8
6
6
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
36
38
28
29
25
In the current month, TMO has received 19 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. TMO average Analyst price target in the past 3 months is 718.83.
Each month's total comprises the sum of three months' worth of ratings.

TMO Financial Forecast

TMO Earnings Forecast

Next quarter’s earnings estimate for TMO is $7.15 with a range of $7.00 to $7.34. The previous quarter’s EPS was $6.68. TMO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year TMO has Performed in-line its overall industry.
Next quarter’s earnings estimate for TMO is $7.15 with a range of $7.00 to $7.34. The previous quarter’s EPS was $6.68. TMO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year TMO has Performed in-line its overall industry.

TMO Sales Forecast

Next quarter’s sales forecast for TMO is $12.85B with a range of $12.71B to $12.99B. The previous quarter’s sales results were $12.14B. TMO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year TMO has Performed in-line its overall industry.
Next quarter’s sales forecast for TMO is $12.85B with a range of $12.71B to $12.99B. The previous quarter’s sales results were $12.14B. TMO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year TMO has Performed in-line its overall industry.

TMO Stock Forecast FAQ

What is TMO’s average 12-month price target, according to analysts?
Based on analyst ratings, Thermo Fisher’s 12-month average price target is 718.83.
    What is TMO’s upside potential, based on the analysts’ average price target?
    Thermo Fisher has 14.44% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is TMO a Buy, Sell or Hold?
          Thermo Fisher has a consensus rating of Strong Buy which is based on 16 buy ratings, 3 hold ratings and 0 sell ratings.
            What is Thermo Fisher’s price target?
            The average price target for Thermo Fisher is 718.83. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $830.00 ,the lowest forecast is $575.00. The average price target represents 14.44% Increase from the current price of $628.15.
              What do analysts say about Thermo Fisher?
              Thermo Fisher’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.
                How can I buy shares of TMO?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.